Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.495 USD | -5.49% | -9.32% | -48.16% |
15/05 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
14/05 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.16% | 13Cr | |
+12.19% | 23TCr | |
+15.65% | 20TCr | |
+19.34% | 14TCr | |
+30.61% | 11TCr | |
+2.78% | 6.47TCr | |
+19.75% | 5.44TCr | |
+5.12% | 5.11TCr | |
+10.68% | 4.5TCr | |
+4.40% | 3.74TCr |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Piper Sandler Adjusts Price Target on Akoya Biosciences to $14 From $18, Reiterates Overweight Rating